000 | 03274nam a2200469Ii 4500 | ||
---|---|---|---|
001 | 9781351138666 | ||
008 | 180727s2018 fluab ob 001 0 eng d | ||
020 |
_a9781351138666 _q(e-book : PDF) |
||
035 | _a(OCoLC)1021061976 | ||
050 | 4 | _aR857.M3 | |
060 | 1 | 0 | _aQT 36.5 |
072 | 7 |
_aMED _x009000 _2bisacsh |
|
072 | 7 |
_aTEC _x021000 _2bisacsh |
|
072 | 7 |
_aTEC _x027000 _2bisacsh |
|
072 | 7 |
_aPHVN _2bicscc |
|
082 | 0 | 4 |
_a610.28 _223 |
245 | 0 | 0 |
_aNanobiomaterials / _cedited by Bhupinder Singh. |
250 | _aFirst edition. | ||
264 | 1 |
_aBoca Raton, FL : _bCRC Press, an imprint of Taylor and Francis, _c2018. |
|
300 |
_a1 online resource (308 pages) : _b175 illustrations |
||
505 | 0 | _achapter 1 Applications of Nanostructured Biomaterials -- chapter 2 Nanocoutured Metallic Biomaterials and Surface Functionalization of Titanium-Based Alloys for Medical Applications -- chapter 3 Graphene-Polymer Nanocomposites for Biomedical Applications -- chapter 4 Lipid-Based Nanocarriers in Lymphatic Transport of Drugs: Retrospect and Prospects -- chapter 5 Nanocarriers in Early Diagnosis of Cancer -- chapter 6 Dendrimers: Emerging Anti-Infective Nanomedicines -- chapter 7 Production and Utilization of Nanofibers as Promising Biomaterials -- chapter 8 Fibro-Porous Composite Nanobiomaterials for Enhanced Biointegration -- chapter 9 Nanocarrier-Mediated Therapeutic Protein Delivery -- chapter 10 Nanotechnology-Based Prodrug Conjugates for Site-Specific Antineoplastic Therapy -- chapter 11 Osteomyelitis: Therapeutic Management using Nanomedicines -- chapter 12 Nanostructured Lipid Carrier-Mediated Methotrexate Delivery Evokes Transcription Factors to Induce Selective Apoptosis in Rheumatoid Arthritis -- chapter 13 Superparamagnetic Iron Oxide Nanoparticles for Magnetic Hyperthermia Applications -- chapter 14 Development of In-House Nano-Hydroxyapatite Particles for Dental Applications. | |
520 | 3 | _aThe present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal ®ulatory issues on the usage of nanobiomaterials have been assigned due consideration. | |
650 | 1 | 2 |
_aNanostructures _xtherapeutic use. _918986 |
650 | 2 | 2 |
_aBiocompatible Materials _xtherapeutic use. _920409 |
650 | 2 | 2 |
_aDrug Delivery Systems. _97290 |
650 | 0 |
_aBiocompatible Materials _xtherapeutic use. _920409 |
|
650 | 0 |
_aDrug Delivery Systems. _97290 |
|
650 | 0 |
_aNanostructures _xtherapeutic use. _918986 |
|
650 | 7 |
_aTECHNOLOGY & ENGINEERING / Material Science. _2bisacsh _97726 |
|
650 | 7 |
_aTECHNOLOGY & ENGINEERING / Nanotechnology & MEMS. _2bisacsh _911045 |
|
650 | 0 |
_aDendrimers. _912820 |
|
650 | 0 |
_aNanocariers. _920410 |
|
650 | 0 |
_aNanofibers. _94298 |
|
650 | 0 |
_aProdrug Conjugates. _920411 |
|
650 | 0 |
_aSilk Nanomaterials. _920412 |
|
650 | 0 |
_aSuperparamagnetic Iron Oxide Nanoparticles. _920413 |
|
700 | 1 |
_aSingh, Bhupinder, _eeditor. _918180 |
|
710 | 2 |
_aTaylor and Francis. _910719 |
|
776 | 0 | 8 |
_iPrint version: _z9780815399780 _w(DLC) 2018000548 |
856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9781351138666 _zClick here to view. |
942 | _cEBK | ||
999 |
_c72374 _d72374 |